CCMU
CHRS icon

Cheyne Capital Management (UK)’s Coherus Oncology CHRS Stock Holding History

Cheyne Capital Management (UK)’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-84,778
Closed -$2.45M – 47
2015
Q2 		$2.45M Buy
+84,778
New +$2.14M 0.79% 16

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cheyne Capital Management (UK)'s CHRS Position: Q3 2015 in Review

Cheyne Capital Management (UK) sold out of Coherus Oncology (CHRS) in Q3 2015, closing a stake of 84,778 shares — an estimated $2.45M sold.

Cheyne Capital Management (UK) first reported a position in CHRS in Q2 2015 and held it in 1 quarter. The position peaked at $2.45M in Q2 2015. 78 funds tracked by Wall St. Rank hold CHRS as of Q3 2015.

  • Cheyne Capital Management (UK) reported no remaining Coherus Oncology position as of Q3 2015 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 84,778 Coherus Oncology shares in Q3 2015, an estimated $2.45M.
  • Cheyne Capital Management (UK) first reported a position in Coherus Oncology in Q2 2015 and held it in 1 quarter.
  • Cheyne Capital Management (UK)'s Coherus Oncology position peaked at $2.45M in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2015.

Based on Cheyne Capital Management (UK)'s 13F filing for Q3 2015, filed 19 Oct 2015.